Wuxi Chemical Equipment Co., Ltd. (SHE:001332)
China · Delayed Price · Currency is CNY 25.83
+0.43 (1.69%)
Sep 14, 2026, 3:04 PM CST
Wuxi Chemical Equipment Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,213 | 1,173 | 1,524 | 1,240 | 1,163 | 1,007 |
Other Revenue | 7.49 | 8.04 | 9.36 | 8.76 | 6.59 | 5.83 |
| 1,220 | 1,181 | 1,534 | 1,248 | 1,170 | 1,013 | |
Revenue Growth | -18.15% | -23.00% | 22.86% | 6.74% | 15.49% | 21.24% |
Cost of Revenue | 799.38 | 763.14 | 1,044 | 986.08 | 806.85 | 639.72 |
Gross Profit | 420.66 | 417.85 | 490.04 | 262.34 | 362.71 | 372.99 |
Selling, General & Admin | 120.15 | 117.79 | 109.48 | 82.96 | 67.61 | 57.52 |
Research & Development | 58.25 | 54.93 | 51.69 | 43.27 | 40.22 | 36.53 |
Other Operating Expenses | 14.22 | 6.72 | 12.34 | 0.13 | 7.51 | 8.3 |
Operating Expenses | 191.71 | 197.38 | 245.82 | 131.16 | 134.99 | 108.87 |
Operating Income | 228.95 | 220.47 | 244.22 | 131.19 | 227.71 | 264.12 |
Interest Expense | - | - | - | - | -0.08 | -0.43 |
Interest & Investment Income | 54.89 | 53.87 | 41.01 | 34.41 | 8.73 | 4.32 |
Currency Exchange Gain (Loss) | -58.23 | -14.5 | 3.5 | 4.8 | 19.41 | -4.94 |
Other Non Operating Income (Expenses) | -0.56 | -0.75 | -0.53 | -1.02 | -0.69 | -0.41 |
EBT Excluding Unusual Items | 225.05 | 259.09 | 288.19 | 169.37 | 255.08 | 262.67 |
Gain (Loss) on Sale of Investments | 2.06 | 0.75 | 0.46 | 0.32 | 0.53 | - |
Gain (Loss) on Sale of Assets | -0 | -0 | 0.02 | 0.01 | 0.01 | 0 |
Asset Writedown | -0.16 | -0.39 | -1.6 | -0.22 | -0 | -0 |
Other Unusual Items | 6.95 | 5.34 | 6.36 | 19.06 | 8.47 | 2.34 |
Pretax Income | 233.9 | 264.78 | 293.44 | 188.53 | 264.1 | 265 |
Income Tax Expense | 31.53 | 37.49 | 38.27 | 23.53 | 33.59 | 35.71 |
Net Income | 202.37 | 227.3 | 255.16 | 165 | 230.5 | 229.29 |
Net Income to Common | 202.37 | 227.3 | 255.16 | 165 | 230.5 | 229.29 |
Net Income Growth | -19.81% | -10.92% | 54.64% | -28.42% | 0.53% | 18.75% |
Shares Outstanding (Basic) | 155 | 154 | 152 | 151 | 123 | 113 |
Shares Outstanding (Diluted) | 155 | 154 | 152 | 151 | 123 | 113 |
Shares Change | 1.58% | 1.62% | 0.68% | 23.05% | 8.16% | 0.09% |
EPS (Basic) | 1.30 | 1.47 | 1.68 | 1.09 | 1.88 | 2.02 |
EPS (Diluted) | 1.30 | 1.47 | 1.68 | 1.09 | 1.88 | 2.02 |
EPS Growth | -21.05% | -12.34% | 53.59% | -41.82% | -7.05% | 18.64% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 132.92 | 264.83 | 186.09 | 194.11 | -128.5 | 117.75 |
Free Cash Flow Per Share | 0.85 | 1.71 | 1.22 | 1.29 | -1.05 | 1.04 |
Dividend Per Share | 0.357 | 0.571 | 0.714 | 0.357 | 1.852 | - |
Dividend Growth | -37.52% | -20.01% | 100.03% | -80.72% | 133.33% | - |
Gross Margin | 34.48% | 35.38% | 31.95% | 21.01% | 31.01% | 36.83% |
Operating Margin | 18.77% | 18.67% | 15.92% | 10.51% | 19.47% | 26.08% |
Profit Margin | 16.59% | 19.25% | 16.64% | 13.22% | 19.71% | 22.64% |
Free Cash Flow Margin | 10.90% | 22.42% | 12.13% | 15.55% | -10.99% | 11.63% |
EBITDA | 273.8 | 264.96 | 275.89 | 159.95 | 251.81 | 288.04 |
EBITDA Margin | 22.44% | 22.44% | 17.99% | 12.81% | 21.53% | 28.44% |
D&A For EBITDA | 44.85 | 44.49 | 31.67 | 28.76 | 24.09 | 23.91 |
EBIT | 228.95 | 220.47 | 244.22 | 131.19 | 227.71 | 264.12 |
EBIT Margin | 18.77% | 18.67% | 15.92% | 10.51% | 19.47% | 26.08% |
Effective Tax Rate | 13.48% | 14.16% | 13.04% | 12.48% | 12.72% | 13.48% |
Revenue as Reported | 1,220 | 1,181 | 1,534 | 1,248 | 1,170 | 1,013 |